Alligator Bioscience AB (publ)
SSE:ATORX.ST
Overview | Financials
Company Name | Alligator Bioscience AB (publ) |
Symbol | ATORX.ST |
Currency | SEK |
Price | 1.178 |
Market Cap | 775,069,812 |
Dividend Yield | 0% |
52-week-range | 0.34 - 1.568 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Søren Bregenholt Ph.D. |
Website | https://www.alligatorbioscience.se |
An error occurred while fetching data.
About Alligator Bioscience AB (publ)
Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based drugs for cancer treatment in Sweden. It develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD